Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics and the preterm infant microbiome
NCT02477423Completed
- Sponsor
- University of Chicago
- Start
- Jul 2015
- Primary completion
- Jun 2019
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Randomised, double-blind trial of ampicillin and gentamicin in sepsis, sponsored by University of Chicago. Primary endpoints: Richness of the Preterm Infant Microbiome at 2 weeks and Shannon Diversity of the Preterm Infant Microbiome at 2 weeks. Started Jul 2015; status: completed.
02
Drugs
ampicillingentamicin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02477423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477423.